Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Janet Pang"'
Autor:
Dat Nguyen, Barbara Schuler, Nancy Harold, Geraldine Morrison, Xaiodu Guo, Maurice A. Wright, Mary G. Quinn, Jorge P. Leguizamo, Janet Pang, Eva Szabo, Gregory D. Leonard, M. Wasif Saif, Suzanne Fioravanti, Brian P. Monahan, Jon L. Hopkins, Pengxin Lin, Jean L. Grem
Publikováno v:
Clinical Cancer Research. 11:4144-4150
Purpose: In preclinical studies, sequential exposure to irinotecan (CPT-11) then fluorouracil (5-FU) is superior to concurrent exposure or the reverse sequence; a 24-hour infusion of CPT-11 may be better tolerated than shorter infusions. Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315c80d9fa45b860a95addad65a8f657
https://doi.org/10.1158/1078-0432.ccr-04-2439
https://doi.org/10.1158/1078-0432.ccr-04-2439
Autor:
Chris H. Takimoto, Dat Nguyen, Alice P. Chen, J. Michael Hamilton, Brian P. Monahan, Janet Pang, Mary G. Quinn, Yan Xu, Jean L. Grem, Anthony Rowedder, Bruce Keith, Nancy Harold, Geraldine Morrison
Publikováno v:
Cancer Chemotherapy and Pharmacology. 52:487-496
Since preclinical studies have shown more than additive cytotoxicity and DNA damage with the combination of gemcitabine and 5-fluoro-2'-deoxyuridine (FUDR), we studied this combination in a phase I trial.Gemcitabine alone was given in cycle 1 as a 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332cce0c9225697893274395cf2a66ee
https://doi.org/10.1007/s00280-003-0698-5
https://doi.org/10.1007/s00280-003-0698-5
Autor:
Jorge P. Leguizamo, Jean L. Grem, Chris H. Takimoto, Abdel Salam Attia Ismail, Janet Pang, Mary G. Quinn, Michael D. Liang, William L. Dahut
Publikováno v:
Cancer Chemotherapy and Pharmacology. 52:333-338
A phase I pharmacologic study was undertaken to determine the maximum tolerated dose (MTD), to characterize the pharmacokinetic profile, and to evaluate all toxicities of the aqueous colloidal dispersion formulation of 9-aminocampothecin (9-AC).9-AC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2c1aa5fdcc6bd155b6faa3fa6e6818
https://doi.org/10.1007/s00280-003-0657-1
https://doi.org/10.1007/s00280-003-0657-1
Autor:
Frank M. Balis, W. Corse, Chris H. Takimoto, David J. Liewehr, Mary Flanagan Quinn, Jean L. Grem, Robert F. Murphy, J M Hamilton, Carmen J. Allegra, Brian P. Monahan, Nancy Harold, Alice P. Chen, Janet Pang, Seth M. Steinberg, R. Lush, Abdel Salam Attia Ismail
Publikováno v:
Cancer Chemotherapy and Pharmacology. 47:117-125
Purpose: Clinical toxicity associated with 5-fluorouracil (5-FU) is related to the area under the plasma concentration-time curve (AUC). Recently, short-term infusions of 5-FU given over 30 or 60 min have been substituted for conventional "bolus" 5-F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95c78225c9ae02d426e76afd3b2de8e
https://doi.org/10.1007/s002800000189
https://doi.org/10.1007/s002800000189
Publikováno v:
The International journal of pharmacy practice. 19(4)
Objectives To describe the relationship between job satisfaction of hospital pharmacists and the extent of their involvement in clinical pharmacy activities, and to examine if demographics and practice characteristics are associated with the extent o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f733c83f06cb53a4632d2b8e61f958ed
https://pubmed.ncbi.nlm.nih.gov/21733013
https://pubmed.ncbi.nlm.nih.gov/21733013
Publikováno v:
Chinese medical journal. 119(19)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b257e60b591709e9b98236e9bd81feb
https://pubmed.ncbi.nlm.nih.gov/17042981
https://pubmed.ncbi.nlm.nih.gov/17042981
Publikováno v:
Pharmacy worldscience : PWS. 27(3)
Antiplatelet drugs are widely used for secondary prevention of thrombotic cerebrovascular disease. The antiplatelet prescribing patterns has been evaluated in several studies but data about Hong Kong patients are lacking. This study is to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2414d10cfb8aaa793d27cbbb8bf203
https://pubmed.ncbi.nlm.nih.gov/16096898
https://pubmed.ncbi.nlm.nih.gov/16096898
Autor:
Jean L, Grem, Nancy, Harold, Bruce, Keith, Alice P, Chen, Viven, Kao, Chris H, Takimoto, J Michael, Hamilton, Janet, Pang, Marie, Pace, Gada B, Jasser, Mary G, Quinn, Brian P, Monahan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(7)
Pyrazoloacridine (PZA) is an investigational nucleic acid binding agent that inhibits the activity of topoisomerases I and II through a mechanism distinct from other topoisomerase poisons. PZA shows schedule-independent cytotoxicity against tumor cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3624f1b22b5c34db1a50c4e91288092f
https://pubmed.ncbi.nlm.nih.gov/12114415
https://pubmed.ncbi.nlm.nih.gov/12114415
Publikováno v:
Pharmacy World & Science; Jun2005, Vol. 27 Issue 3, p258-262, 5p
Publikováno v:
Journal of Food Science. 49:10-13
A lithium acetate-dimethyl sulfoxide ninhydrin reagent was shown to be useful for reaction of amino groups in a series of structurally diverse food proteins and flours of variable lysine content. The proteins were bovine serum albumin, casein, hemogl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c32a97b47193d0c608d2784da4354c6
https://doi.org/10.1111/j.1365-2621.1984.tb13656.x
https://doi.org/10.1111/j.1365-2621.1984.tb13656.x